Summit Investment Advisors »

Fate Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $29k 8.4k 3.50
2024-06-30 $27k 8.4k 3.28
2024-03-31 $61k 8.4k 7.34
2023-12-31 $31k 8.4k 3.74
2023-09-30 $18k 8.4k 2.12
2023-06-30 $30k 6.3k 4.76
2023-03-31 $36k 6.3k 5.70
2022-12-31 $35k 6.3k 5.55
2022-09-30 $141k 6.3k 22.40
2022-06-30 $155k 6.3k 24.63
2022-03-31 $244k 6.3k 38.77
2021-12-31 $368k 6.3k 58.47
2021-09-30 $373k 6.3k 59.26
2021-06-30 $546k 6.3k 86.75
2021-03-31 $511k 6.2k 82.50
2020-12-31 $546k 6.0k 91.00
2020-09-30 $244k 6.1k 39.97
2020-06-30 $190k 5.5k 34.34
2020-03-31 $116k 5.2k 22.25
2019-12-31 $102k 5.2k 19.56
2019-09-30 $69k 4.4k 15.55
2019-06-30 $90k 4.4k 20.28
2019-03-31 $88k 5.0k 17.50
2018-12-31 $53k 4.1k 12.93
2018-09-30 $67k 4.1k 16.34
2018-06-30 $46k 4.1k 11.22
2018-03-31 $40k 4.1k 9.76
2017-12-31 $20k 3.3k 5.98
2017-09-30 $12k 3.3k 3.59
2017-06-30 $11k 3.3k 3.29